mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.0004 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0004 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0004 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |